Comparison of Laboratory Methods for the Clinical Follow Up of Checkpoint Blockade Therapies in Leukemia: Current Status and Challenges Ahead

The development of immune checkpoint inhibitors, the monoclonal antibodies that modulate the interaction between immune checkpoint molecules or their ligands on the immune cells or tumor tissue has revolutionized cancer treatment. While there are various studies proving their efficacy in hematologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Aru, Basak, Soltani, Mojdeh, Pehlivanoglu, Cemil, Gürlü, Ege, Ganjalikhani-Hakemi, Mazdak, Yanikkaya Demirel, Gülderen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829140/
https://www.ncbi.nlm.nih.gov/pubmed/35155232
http://dx.doi.org/10.3389/fonc.2022.789728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829140/
https://www.ncbi.nlm.nih.gov/pubmed/35155232
http://dx.doi.org/10.3389/fonc.2022.789728

Ejemplares similares